FDA — authorised 28 November 1990
- Status: approved
🇺🇸 Vaniqa in United States
FDA authorised Vaniqa on 28 November 1990
Marketing authorisations
FDA — authorised 27 July 2000
- Application: NDA021145
- Marketing authorisation holder: ABBVIE
- Local brand name: VANIQA
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 13 December 2023
- Application: NDA215500
- Marketing authorisation holder: USWM
- Indication: Type 5 - New Formulation or New Manufacturer
- Status: approved
Vaniqa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Vaniqa approved in United States?
Yes. FDA authorised it on 28 November 1990; FDA authorised it on 27 July 2000; FDA authorised it on 13 December 2023.
Who is the marketing authorisation holder for Vaniqa in United States?
Marketing authorisation holder not available in our data.